AAF
Andra AP-fonden Portfolio holdings
AUM
$7.19B
This Quarter Return
-21.13%
1 Year Return
+17.43%
3 Year Return
+74.99%
5 Year Return
–
10 Year Return
–
AUM
$2.75B
AUM Growth
+$2.75B
(-21%)
Cap. Flow
+$142M
Cap. Flow
% of AUM
5.18%
Top 10 Holdings %
Top 10 Hldgs %
3.64%
Holding
676
New
10
Increased
405
Reduced
247
Closed
12
Top Buys
| 1 |
Centene
CNC
|
$6.49M |
| 2 |
Prologis
PLD
|
$4.15M |
| 3 |
Equitable Holdings
EQH
|
$3.96M |
| 4 |
Newmont
NEM
|
$2.88M |
| 5 |
Zillow
Z
|
$2.83M |
Top Sells
| 1 |
Canadian National Railway
CNI
|
$11.5M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$7.53M |
| 3 |
Howmet Aerospace
HWM
|
$6.76M |
| 4 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
$5.42M |
| 5 |
LPT
Liberty Property Trust
LPT
|
$5.24M |
Sector Composition
| 1 | Financials | 15.69% |
| 2 | Technology | 15.43% |
| 3 | Healthcare | 14.55% |
| 4 | Consumer Discretionary | 11.24% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Prologis
PLD
$106B
| $11.8M | 0.43% | 146,400 +51,600 | +54% | +$4.15M |
|
|
2
Centene
CNC
$14.3B
| $11.7M | 0.43% | 197,600 +109,300 | +124% | +$6.49M |
|
3
Biogen
BIIB
$19.4B
| $10.3M | 0.37% | 32,500 +2,800 | +9% | +$886K |
|
4
Vipshop
VIPS
$8.25B
| $10.3M | 0.37% | 658,000 -171,300 | -21% | -$2.67M |
|
|
CTXS
5
DELISTED
Citrix Systems Inc
CTXS
| $9.84M | 0.36% | 69,500 -2,800 | -4% | -$396K |
|
6
Kroger
KR
$44.9B
| $9.77M | 0.36% | 324,300 +19,300 | +6% | +$581K |
|
7
Gilead Sciences
GILD
$140B
| $9.56M | 0.35% | 127,900 +10,600 | +9% | +$792K |
|
8
Bristol-Myers Squibb
BMY
$96B
| $9.26M | 0.34% | 166,200 +4,600 | +3% | +$256K |
|
9
JD.com
JD
$44.1B
| $9M | 0.33% | 222,100 +15,800 | +8% | +$640K |
|
|
S
10
DELISTED
Sprint Corporation
S
| $8.68M | 0.32% | 1,006,500 +183,700 | +22% | +$1.58M |
|
11
Eli Lilly
LLY
$657B
| $8.64M | 0.31% | 62,300 +15,400 | +33% | +$2.14M |
|
12
UnitedHealth
UNH
$281B
| $8.33M | 0.3% | 33,400 +5,500 | +20% | +$1.37M |
|
13
Cigna
CI
$80.3B
| $8.27M | 0.3% | 46,700 +7,900 | +20% | +$1.4M |
|
14
Clorox
CLX
$14.5B
| $8.2M | 0.3% | 47,300 +12,900 | +38% | +$2.24M |
|
15
Campbell Soup
CPB
$9.52B
| $8.17M | 0.3% | 177,000 -10,200 | -5% | -$471K |
|
16
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.11M | 0.29% | 16,600 +4,700 | +39% | +$2.3M |
|
17
Humana
HUM
$36.5B
| $8.1M | 0.29% | 25,800 +3,900 | +18% | +$1.22M |
|
18
Kimberly-Clark
KMB
$42.8B
| $8.07M | 0.29% | 63,100 +6,700 | +12% | +$857K |
|
19
Amgen
AMGN
$155B
| $7.93M | 0.29% | 39,100 +1,400 | +4% | +$284K |
|
20
General Mills
GIS
$26.4B
| $7.85M | 0.29% | 148,800 +1,700 | +1% | +$89.7K |
|
21
Hormel Foods
HRL
$14B
| $7.71M | 0.28% | 165,400 +48,200 | +41% | +$2.25M |
|
22
AbbVie
ABBV
$372B
| $7.63M | 0.28% | 100,100 +300 | +0.3% | +$22.9K |
|
23
Crown Castle
CCI
$43.2B
| $7.61M | 0.28% | 52,700 +7,900 | +18% | +$1.14M |
|
24
Target
TGT
$43.6B
| $7.56M | 0.27% | 81,300 +100 | +0.1% | +$9.3K |
|
25
Merck
MRK
$210B
| $7.54M | 0.27% | 98,000 +6,800 | +7% | +$523K |
|